EUA
Real-Time Fluorescent RT-PCR Kit for Detecting SARS-CoV-2
FDA Emergency Use Authorization · BGI Genomics Co. Ltd · Apr 26, 2022
Key facts
| Product | Real-Time Fluorescent RT-PCR Kit for Detecting SARS-CoV-2 |
|---|---|
| Company | BGI Genomics Co. Ltd |
| Product type | Real-time RT-PCR, Single Target |
| Date | Apr 26, 2022 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: